199 related articles for article (PubMed ID: 10741925)
1. Chemoembolization of hepatic metastases from intestinal neuroendocrine tumours.
Kirchhoff T; Chavan A; Galanski M
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):141-3. PubMed ID: 10741925
[TBL] [Abstract][Full Text] [Related]
2. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours.
Toumpanakis C; Meyer T; Caplin ME
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):131-44. PubMed ID: 17382269
[TBL] [Abstract][Full Text] [Related]
4. Natural history of liver metastasis of gastroenteropancreatic neuroendocrine tumors: place for chemoembolization.
Proye C
World J Surg; 2001 Jun; 25(6):685-8. PubMed ID: 11376397
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial hepatic chemoembolization in liver metastases from neuroendocrine tumors: a phase II study.
Fiorentini G; Rossi S; Bonechi F; Vaira M; De Simone M; Dentico P; Bernardeschi P; Cantore M; Guadagni S
J Chemother; 2004 Jun; 16(3):293-7. PubMed ID: 15330328
[TBL] [Abstract][Full Text] [Related]
6. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
[TBL] [Abstract][Full Text] [Related]
7. Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors.
Desai DC; O'Dorisio TM; Schirmer WJ; Jung SS; Khabiri H; Villanueva V; Martin EW
Regul Pept; 2001 Jan; 96(3):113-7. PubMed ID: 11111016
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
10. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
[TBL] [Abstract][Full Text] [Related]
12. Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial.
Chen JX; Wileyto EP; Soulen MC
Trials; 2018 Jul; 19(1):390. PubMed ID: 30016989
[TBL] [Abstract][Full Text] [Related]
13. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
Nakakura EK; Venook AP; Bergsland EK
Surg Oncol Clin N Am; 2007 Jul; 16(3):639-51, x. PubMed ID: 17606198
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for gastro-enteropancreatic endocrine tumours.
O'Toole D; Hentic O; Corcos O; Ruszniewski P
Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial embolization in patients with neuroendocrine tumors.
Del Prete M; Fiore F; Modica R; Marotta V; Marciello F; Ramundo V; Di Sarno A; Carratù A; di Roseto Cde L; Tafuto S; Tatangelo F; Baldelli R; Colao A; Faggiano A;
J Exp Clin Cancer Res; 2014 May; 33(1):43. PubMed ID: 24887262
[TBL] [Abstract][Full Text] [Related]
16. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry LJ; Stuart K; Stokes KR; Clouse ME
Surgery; 1994 Dec; 116(6):1111-6; discussion 1116-7. PubMed ID: 7985095
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
20. Interventional treatment of neuroendocrine liver metastases.
Knigge U; Hansen CP; Stadil F
Surgeon; 2008 Aug; 6(4):232-9. PubMed ID: 18697366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]